Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells

Clinical and Experimental Immunology

Volumn 173, Issue 2, 2013, Pages 355-364

  Buchner S M ^a   Sliva, K ^a   Bonig, H ^b   Volker I ^a   Waibler, Z ^a   Kirberg, J ^a   Schnierle, B S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Graft versus host disease (GVHD); Immunodeficiency primary; MHC class II

Indexed keywords

HLA DQ8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SURVIVAL RATE;

GRAFT-VERSUS-HOST DISEASE (GVHD); IMMUNODEFICIENCY-PRIMARY; MHC CLASS II;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; DISEASE PROGRESSION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNITY, HUMORAL; IMMUNOCOMPROMISED HOST; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 84880006743     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12121     Document Type: Article

References (33)

1. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527-530.
2. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992; 255:1137-1141.
3. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256-259.
4. Lieber MR, Hesse JE, Lewis S etal. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 1988; 55:7-16.
5. Blunt T, Finnie NJ, Taccioli GE etal. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995; 80:813-823.
6. Blunt T, Gell D, Fox M etal. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci USA 1996; 93:10285-10290.
7. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68:869-877.
8. Shinkai Y, Koyasu S, Nakayama K etal. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 1993; 259:822-825.
9. Dorshkind K, Pollack SB, Bosma MJ, Phillips RA. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J Immunol 1985; 134:3798-3801.
10. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-244.
11. Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997; 186:1269-1275.
12. van Rijn RS, Simonetti ER, Hagenbeek A etal. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood 2003; 102:2522-2531.
13. Gimeno R, Weijer K, Voordouw A etal. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. Blood 2004; 104:3886-3893.
14. Legrand N, Cupedo T, van Lent AU etal. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in 'human immune system' Rag2(-/-)gammac(-/-) mice. Blood 2006; 108:238-245.
15. Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 2006; 176:2053-2058.
16. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29:1-13.
17. Hudson WA, Li Q, Le C, Kersey JH. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects. Leukemia 1998; 12:2029-2033.
18. Watanabe Y, Takahashi T, Okajima A etal. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 2009; 21:843-858.
19. Ogasawara K, Hamerman JA, Hsin H etal. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003; 18:41-51.
20. Matsumura T, Kametani Y, Ando K etal. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol 2003; 31:789-797.
21. Ito M, Kobayashi K, Nakahata T. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol 2008; 324:53-76.
22. Wege AK, Melkus MW, Denton PW, Estes JD, Garcia JV. Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008; 324:149-165.
23. Ito R, Katano I, Kawai K etal. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 2009; 87:1654-1658.
24. Imadome K, Yajima M, Arai A etal. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog 2011; 7:e1002326.
25. King MA, Covassin L, Brehm MA etal. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157:104-118.
26. Hayward SL, Bautista-Lopez N, Suzuki K, Atrazhev A, Dickie P, Elliott JF. CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice. J Immunol 2006; 176:7715-7725.
27. Cosgrove D, Gray D, Dierich A etal. Mice lacking MHC class II molecules. Cell 1991; 66:1051-1066.
28. Nabozny GH, Baisch JM, Cheng S etal. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996; 183:27-37.
29. Shultz LD, Saito Y, Najima Y etal. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci USA 2010; 107:13022-13027.
30. Jaiswal S, Pearson T, Friberg H etal. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-SCID IL2rgammanull mice. PLoS ONE 2009; 4:e7251.
31. Danner R, Chaudhari SN, Rosenberger J etal. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE 2011; 6:e19826.
32. Cooke KR, Hill GR, Crawford JM etal. Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998; 102:1882-1891.
33. Covassin L, Laning J, Abdi R etal. Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rgamma(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen d-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clin Exp Immunol 2011; 166:269-280.